FDA Commissioner Dr. Marty Makary faces ousting amid policy clashes with Trump

Dr. Marty Makary, the current commissioner of the Food and Drug Administration (FDA), is set to be dismissed by President Donald Trump. The decision follows ongoing clashes over key health policies, including vaping regulations, oversight of the abortion pill, and the rejection of certain drug applications. Makary, a former cancer surgeon and health policy researcher, had become one of the most visible leaders in the agency’s history.

Makary’s tenure at the FDA was marked by both popularity and controversy. He frequently appeared on television and podcasts to discuss his work, raising the agency’s public profile. His supporters praised moves like expanding access to hormone replacement therapies and accelerating approval for a pancreatic cancer treatment. Yet, these decisions also drew criticism from biotech firms and investors, particularly when the FDA rejected treatments for rare diseases.

Pressure mounted from multiple sides. Abortion opponents, including Susan B. Anthony Pro-Life America, demanded his removal over his handling of mifepristone, the abortion pill. Meanwhile, the White House reportedly pushed him to approve flavoured e-cigarettes, such as blueberry and mango varieties produced by Glas. These conflicts left Makary struggling to balance business-friendly policies with the concerns of agency staff and public health advocates. Before leading the FDA, Makary worked as a cancer surgeon and researcher at Johns Hopkins University School of Medicine. His background in health policy shaped his approach, but it wasn’t enough to shield him from political and industry backlash. While President Trump has approved the plan to fire him, the decision may still shift, given the president’s history of reversing course.

The potential dismissal of Dr. Makary leaves the FDA facing uncertainty. His exit would follow disputes over vaping rules, drug approvals, and reproductive health policies. The final decision now rests with the White House, where last-minute changes remain possible.